B Fast Blood First Assay Screening Trial Umbrella Study
Research payments
$1,378,978
Through program year 2020, $1,378,978 in research payments was reported against B Fast Blood First Assay Screening Trial Umbrella Study, across 287 payments.
- Paid by (largest first)
- Genentech, Inc.; F. Hoffmann-La Roche AG; Hoffmann-La Roche Limited
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $900,599 | 158 |
| 2019 | Research | $478,379 | 129 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Haiying Cheng Bronx, NY Named on 25 payments
- Konstantin Dragnev Lebanon, NH Named on 25 payments
- Conrad Wittram Coeur D Alene, ID Named on 18 payments
- Vinay Duddalwar Los Angeles, CA Named on 17 payments
- Davey Daniel Chattanooga, TN Named on 16 payments
- Melissa Johnson Nashville, TN Named on 15 payments
- Robert Jotte Lone Tree, CO Named on 14 payments
- James Reeves Fort Myers, FL Named on 14 payments
- Brian Vicuna Las Vegas, NV Named on 13 payments
- Craig Reynolds Ocala, FL Named on 12 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.